Characterising the progress in HIV/AIDS research in the Middle East and North Africa

Hanan F. Saba, Silva Kouyoumjian, Ghina R. Mumtaz, Laith Aburaddad

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objectives The Middle East and North Africa (MENA) region is perceived to have limited HIV data. The objective of this study was to quantitatively characterise the progress in HIV research in this region since the discovery of the epidemic. Methods Four indices were defined and implemented to measure the progress of HIV research using the PubMed, Embase, MENA HIV/AIDS Epidemiology Synthesis Project and US Census Bureau HIV/AIDS Surveillance databases. The four indices provide complementary measures to characterise different aspects of the progress of HIV research. Results A total of 2118, 2352, 683 and 4889 records were identified through the PubMed, the Embase, the Synthesis Project and the HIV Prevalence indices, respectively. The proportion of the total global HIV records that relate to MENA is 1.2%. Overall, the indices show steady progress in the number of new records every year, with an accelerated pace in the last few years. The rate of progress in MENA was also higher than the rate of progress in HIV records globally. There is no evidence so far of stabilisation or a peak in the number of new records year by year. About half of the records were produced after the year 2005. The number of records shows large heterogeneity across countries. Conclusions MENA has witnessed a rapid growth in HIV research over the last decade. However, there are still large gaps in HIV scientific evidence in the region, and the progress is far from being uniform across countries. Ongoing and future research needs to be geared towards academic standard and production of scientific publications.

Original languageEnglish
JournalSexually Transmitted Infections
Volume89
Issue numberSUPPL. 3
DOIs
Publication statusPublished - 2013

Fingerprint

Northern Africa
Eastern Africa
Middle East
Acquired Immunodeficiency Syndrome
HIV
Research
PubMed
Censuses
Publications
Epidemiology
Databases

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

Characterising the progress in HIV/AIDS research in the Middle East and North Africa. / Saba, Hanan F.; Kouyoumjian, Silva; Mumtaz, Ghina R.; Aburaddad, Laith.

In: Sexually Transmitted Infections, Vol. 89, No. SUPPL. 3, 2013.

Research output: Contribution to journalArticle

@article{4693a9b290284fbeb623e302ac1c951e,
title = "Characterising the progress in HIV/AIDS research in the Middle East and North Africa",
abstract = "Objectives The Middle East and North Africa (MENA) region is perceived to have limited HIV data. The objective of this study was to quantitatively characterise the progress in HIV research in this region since the discovery of the epidemic. Methods Four indices were defined and implemented to measure the progress of HIV research using the PubMed, Embase, MENA HIV/AIDS Epidemiology Synthesis Project and US Census Bureau HIV/AIDS Surveillance databases. The four indices provide complementary measures to characterise different aspects of the progress of HIV research. Results A total of 2118, 2352, 683 and 4889 records were identified through the PubMed, the Embase, the Synthesis Project and the HIV Prevalence indices, respectively. The proportion of the total global HIV records that relate to MENA is 1.2{\%}. Overall, the indices show steady progress in the number of new records every year, with an accelerated pace in the last few years. The rate of progress in MENA was also higher than the rate of progress in HIV records globally. There is no evidence so far of stabilisation or a peak in the number of new records year by year. About half of the records were produced after the year 2005. The number of records shows large heterogeneity across countries. Conclusions MENA has witnessed a rapid growth in HIV research over the last decade. However, there are still large gaps in HIV scientific evidence in the region, and the progress is far from being uniform across countries. Ongoing and future research needs to be geared towards academic standard and production of scientific publications.",
author = "Saba, {Hanan F.} and Silva Kouyoumjian and Mumtaz, {Ghina R.} and Laith Aburaddad",
year = "2013",
doi = "10.1136/sextrans-2012-050888",
language = "English",
volume = "89",
journal = "Sexually Transmitted Infections",
issn = "1368-4973",
publisher = "BMJ Publishing Group",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Characterising the progress in HIV/AIDS research in the Middle East and North Africa

AU - Saba, Hanan F.

AU - Kouyoumjian, Silva

AU - Mumtaz, Ghina R.

AU - Aburaddad, Laith

PY - 2013

Y1 - 2013

N2 - Objectives The Middle East and North Africa (MENA) region is perceived to have limited HIV data. The objective of this study was to quantitatively characterise the progress in HIV research in this region since the discovery of the epidemic. Methods Four indices were defined and implemented to measure the progress of HIV research using the PubMed, Embase, MENA HIV/AIDS Epidemiology Synthesis Project and US Census Bureau HIV/AIDS Surveillance databases. The four indices provide complementary measures to characterise different aspects of the progress of HIV research. Results A total of 2118, 2352, 683 and 4889 records were identified through the PubMed, the Embase, the Synthesis Project and the HIV Prevalence indices, respectively. The proportion of the total global HIV records that relate to MENA is 1.2%. Overall, the indices show steady progress in the number of new records every year, with an accelerated pace in the last few years. The rate of progress in MENA was also higher than the rate of progress in HIV records globally. There is no evidence so far of stabilisation or a peak in the number of new records year by year. About half of the records were produced after the year 2005. The number of records shows large heterogeneity across countries. Conclusions MENA has witnessed a rapid growth in HIV research over the last decade. However, there are still large gaps in HIV scientific evidence in the region, and the progress is far from being uniform across countries. Ongoing and future research needs to be geared towards academic standard and production of scientific publications.

AB - Objectives The Middle East and North Africa (MENA) region is perceived to have limited HIV data. The objective of this study was to quantitatively characterise the progress in HIV research in this region since the discovery of the epidemic. Methods Four indices were defined and implemented to measure the progress of HIV research using the PubMed, Embase, MENA HIV/AIDS Epidemiology Synthesis Project and US Census Bureau HIV/AIDS Surveillance databases. The four indices provide complementary measures to characterise different aspects of the progress of HIV research. Results A total of 2118, 2352, 683 and 4889 records were identified through the PubMed, the Embase, the Synthesis Project and the HIV Prevalence indices, respectively. The proportion of the total global HIV records that relate to MENA is 1.2%. Overall, the indices show steady progress in the number of new records every year, with an accelerated pace in the last few years. The rate of progress in MENA was also higher than the rate of progress in HIV records globally. There is no evidence so far of stabilisation or a peak in the number of new records year by year. About half of the records were produced after the year 2005. The number of records shows large heterogeneity across countries. Conclusions MENA has witnessed a rapid growth in HIV research over the last decade. However, there are still large gaps in HIV scientific evidence in the region, and the progress is far from being uniform across countries. Ongoing and future research needs to be geared towards academic standard and production of scientific publications.

UR - http://www.scopus.com/inward/record.url?scp=84891852927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891852927&partnerID=8YFLogxK

U2 - 10.1136/sextrans-2012-050888

DO - 10.1136/sextrans-2012-050888

M3 - Article

C2 - 23596206

AN - SCOPUS:84891852927

VL - 89

JO - Sexually Transmitted Infections

JF - Sexually Transmitted Infections

SN - 1368-4973

IS - SUPPL. 3

ER -